• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Monica Di Venere, Petra Hamerlik, +8 authors Jeremy N Rich
  • Medicine, Biology
  • Cell Death and Differentiation
  • 2014 (First Publication: 1 February 2014)
  • Glioblastoma-initiating cells (GICs) are self-renewing tumorigenic sub-populations, contributing to therapeutic resistance via decreased sensitivity to ionizing radiation (IR). GIC survival followingContinue Reading
  • Qiuji Wu, Awatef Allouch, Isabelle Martins, Nazanine Modjtahedi, Eric Deutsch, Jean-Luc Perfettini
  • Biology, Medicine
  • Biomedical journal
  • 2017 (First Publication: 1 August 2017)
  • Radiation therapy is one of the major therapeutic modalities for most solid tumors. The anti-tumor effect of radiation therapy consists of the direct tumor cell killing, as well as the modulation ofContinue Reading
  • Qiuji Wu, Awatef Allouch, +18 authors Jean-Luc Perfettini
  • Medicine, Biology
  • Cell Death and Differentiation
  • 2017 (First Publication: 1 September 2017)
  • Although tumor-associated macrophages have been extensively studied in the control of response to radiotherapy, the molecular mechanisms involved in the ionizing radiation-mediated activation ofContinue Reading
  • Qiuji Wu, Xinyuan Wang, Mengxi Zhang, Weiting Liao, Feng Wang, Qiu Li
  • Medicine
  • Oncology research and treatment
  • 2020 (First Publication: 18 March 2020)
  • BACKGROUND The aim of the current study was to estimate two protocols for HER2-negative locally recurrent or metastatic breast cancer patients, bevacizumab combined with paclitaxel versus bevacizumabContinue Reading
  • Qiuji Wu, Weiting Liao, Jia-xing Huang, Pengfei Zhang, Nan Zhang, Qiu Li
  • Medicine
  • Oral oncology
  • 2020 (First Publication: 15 February 2020)
  • BACKGROUND Recently, patients who received induction chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma were found to have survival advantagesContinue Reading